Key Insights

Highlights

Treatment Research

1 treatments under study, led by Chest Wall Breast Radiation With Or Without Lymph Node Region Radiationfor All Of The Enrolled Patients

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06197581Not ApplicableRecruitingPrimary

Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer

Showing all 1 trials

Research Network

Common Treatments

  • Chest Wall Breast Radiation With Or Without Lymph Node Region Radiationfor All Of The Enrolled Patients1

Active Sponsors

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Top Investigators

  • Yirui Zhai, MD1

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences

  • Fei Ma, MD1

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences

  • Bo Lan, MD1

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences

  • Shulian Wang, MD1

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Related Conditions

  • Radiotherapy Complications1
  • Chemotherapeutic Toxicity1
  • Pertuzumab1
  • Trastuzumab1
  • Cdk46 Inhibitor1

Activity Timeline